Search Results - Yingpeng Liu
- Showing 1 - 4 results of 4
-
1
-
2
Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal by Ailing Li, Xiaoyan Lin, Amey Dhopeshwarkar, Ana C. Thomaz, Lawrence M. Carey, Yingpeng Liu, Spyros P. Nikas, Alexandros Makriyannis, Ken Mackie, Andrea G. Hohmann
Published 2018Artigo -
3
-
4
Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma by Ke Xu, Tao Gu, Ke Su, Xin Liu, Bingsheng He, Jie He, Hao Chi, Xuancheng Zhou, Hanlin Liu, M. Xiao, Xue Tang, Qinni Ye, Xuedong Zhou, Yingpeng Liu, Jie Xiong, Pan Wang, Han Li, Kun He, Lu Guo, Yunwei Han
Published 2025Artigo
Search Tools:
Related Subjects
Biochemistry
Chemistry
Medicine
Agonist
Allodynia
Biology
Cancer research
Cannabinoid
Cannabinoid receptor
Cannabinoid receptor type 2
Cell biology
Cell culture
Cognitive psychology
Corneal epithelium
Epithelium
Gene
Gene expression
Genetics
Hepatocellular carcinoma
Hyperalgesia
Immune system
Immunology
In situ hybridization
Molecular biology
Morphine
Neuropathic pain
Neuroscience
Nociception
Oncology
Opioid